openPR Logo
Press release

Tinea Versicolor treatment Market 2018 | Major Leading Players Astellas Pharma US, Inc., Bayer AG, Enzon Pharmaceuticals, Inc. , Galderma S.A. , Gilead , Novartis AG - |Forecast 2023

09-06-2018 03:45 PM CET | Health & Medicine

Press release from: Market Research Future

Tinea Versicolor treatment Market 2018 | Major Leading Players

Market Research Future Present’s “Global Tinea Versicolor Treatment Market Size, Status and Forecast 2022” magnify the decision making potentiality and helps to create an effective counter strategies to gain competitive advantage. The report provides an extensive research and detailed analysis of the present market along with future outlook.

Tinea Versicolor Treatment Market -Overview

Tinea Versicolor is one of the common types of skin infection. It also called as pityriasis versicolor. In this condition, small and discolored patches of skin occur, mostly affecting the shoulders and trunk.

Increasing prevalence of tinea versicolor, increasing awareness of the disease, rising healthcare expenditure, advanced diagnosis and treatment options, and approval of new antifungal medicines are leading the growth of global tinea versicolor treatment market.

Global tinea versicolor treatment market is expected to grow at the CAGR of ~7.1% during the forecast period and is estimated to reach USD 197.9 million by 2023.

Tinea Versicolor Treatment Market -Market Segments

Global tinea versicolor treatment market has been segmented on the basis of diagnosis which comprise physical exam, imaging tests, and others. Imaging test is sub-segmented into wood lamp (black light) examination, microscopy using potassium hydroxide (KOH), fungal culture, skin biopsy, and others. Skin biopsy is sub-segmented into shave biopsy, punch biopsy, excisional biopsy, and others.

On the basis of treatments, the market has been segmented into antifungal shampoos, antifungal creams, drugs, and others. Antifungal shampoos are sub-segmented into selenium sulfide (selsun) 2.5 percent shampoo, ciclopirox (loprox, penlac) shampoo, ketoconazole (ketoconazole, nizoral, others) shampoo, and others.

Antifungal creams are sub-segmented into Selenium sulfide (Selsun) 2.5 percent lotion, Ciclopirox (Loprox, Penlac) cream or gel, Ketoconazole (Ketoconazole, Nizoral, others) cream or gel, and others. Drugs are further sub-segmented into fluconazole (diflucan) tablets or oral solution, and others.

Get PDF with Technological Advancement @ https://www.marketresearchfuture.com/sample_request/3878

Tinea Versicolor Treatment Market -Key developments

Major players in the market are engaged in the development of new products to capture the market globally. Thus, key market players are investing more in research and development activity, in order to lead the global market. In this regards, market players undertake various strategic approaches.

In March 2016, Novartis cancer drug gets FDA's principal 'biosimilar' affirmation. Federal regulators have permitted the first “biosimilar” drug to be sold in the U.S. under a program intended to branch a new market of lower-cost substitutes to some of the most expensive treatments in healthcare.

In May 2016, Novartis studies new sales model for tentative cancer therapy. Novartis strategies to use a medical device-like sales model to market its CAR T-cell technology if the new cancer treatment receives FDA approval.

Tinea Versicolor Treatment Market -Regional Analysis

Considering the global scenario of the market, America is the top contributor in this market. The Americas mainly include North America and South America. Due to large amount of money invested in research, clinical trials, and new product development, US is the dominating country in this region. Europe is the second largest market for tinea versicolor treatment.

Germany is dominating this market while UK is the fastest growing tinea versicolor treatment market. Asia Pacific is witnessing rapid growth in this market which is mainly due to rapidly improving healthcare facilities, increasing awareness of disease, and rising healthcare expenditure. Middle East & Africa is expected to have limited growth.

Obtain Report Details with Technological Advancement @ https://www.marketresearchfuture.com/reports/tinea-versicolor-treatment-market-3878

Tinea Versicolor Treatment Market -Key Players

Astellas Pharma US, Inc. (Japan)
Bayer AG (German)
Enzon Pharmaceuticals, Inc. (US)
Galderma S.A. (Switzerland)
Gilead (US)
Novartis AG (Switzerland)
Pfizer Inc. (US)
Taro Pharmaceutical Industries Ltd. (US)
Teva Pharmaceutical Industries Ltd. (Israel)
Valeant (Canada)

Major Points form TOC for Tinea Versicolor Treatment Market Research Report – Forecast to 2023

Chapter 1. Report Prologue

Chapter 2. Market Introduction

Chapter 3. Research Methodology

Chapter 4. Market Dynamics

Chapter 5. Market Factor Analysis

Chapter 6. Global Tinea Versicolor Treatment Market, By Type

Chapter 7. Global Tinea Versicolor Treatment Market, By Treatment

Chapter 8 Global Tinea Versicolor Treatment Market, By End User

Chapter 9. Global Tinea Versicolor Treatment Market, By Region

Chapter 10. Company Landscape

Chapter 11. Company Profiles

Chapter 12. MRFR Conclusion

Chapter 13. Appendix

GetExcusiveDiscount@https://www.marketresearchfuture.com/check-discount/3878

About US:

Market Research Future (MRFR), enable customers to unravel the complexity of various industries through Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

Contact Us:

Market Research Future

Office No. 528, Amanora Chambers

Magarpatta Road, Hadapsar,

Pune - 411028

Maharashtra, India

Phone: +1 646 845 9312

Email: sales@marketresearchfuture.com

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Tinea Versicolor treatment Market 2018 | Major Leading Players Astellas Pharma US, Inc., Bayer AG, Enzon Pharmaceuticals, Inc. , Galderma S.A. , Gilead , Novartis AG - |Forecast 2023 here

News-ID: 1224988 • Views:

More Releases from Market Research Future

Hydrofluoric Acid Market (CAGR) of 4%, Innovation Imperative Future Proofing Your Business with Market Size
Hydrofluoric Acid Market (CAGR) of 4%, Innovation Imperative Future Proofing You …
Hydrofluoric acid (HF) is a crucial chemical compound with a wide range of applications across various industries. Despite its hazardous nature, it plays an essential role in manufacturing processes, especially in the production of fluorine compounds. The global hydrofluoric acid market has been witnessing steady growth, driven by demand from end-user industries such as oil refining, pharmaceuticals, and electronics. The Hydrodesulfurization Catalysts Market is projected to register a CAGR of over
Palm Methyl Ester Derivative Market Size Projected to Grow at 5.92% CAGR, Reaching USD 2.4 billion by 2030
Palm Methyl Ester Derivative Market Size Projected to Grow at 5.92% CAGR, Reachi …
In recent years, the global market for palm methyl ester derivatives has witnessed significant growth, driven by various factors including environmental concerns, technological advancements, and the increasing demand for sustainable alternatives in various industries. Palm methyl ester derivatives, derived from palm oil, have emerged as versatile ingredients with applications spanning across sectors such as cosmetics, pharmaceuticals, lubricants, and more. The Palm Methyl Ester Derivative Market Size was valued at USD 1.5
Asia-Pacific Ceramic Tiles Market to Register Highest CAGR Growth of 7.50% by 2032: Analysis by Segmentation, Competitors Analysis
Asia-Pacific Ceramic Tiles Market to Register Highest CAGR Growth of 7.50% by 20 …
The Asia-Pacific ceramic tiles market has been witnessing robust growth, driven by various factors such as increasing investments in residential and commercial construction, renovation activities, and the growing preference for aesthetically pleasing and durable flooring solutions. Countries like China, India, Japan, and South Korea have been leading the market growth, supported by strong manufacturing capabilities, technological advancements, and evolving consumer preferences. Asia-Pacific Ceramic Tiles Market Size was valued at USD 141.2
APAC Wallpaper Market to Register Highest CAGR Growth of 8% by 2032: Analysis by Segmentation, Competitors Analysis
APAC Wallpaper Market to Register Highest CAGR Growth of 8% by 2032: Analysis by …
The APAC wallpaper market has witnessed significant growth in recent years, driven by factors such as rising disposable incomes, expanding construction activities, and growing awareness regarding interior decor. Countries like China, India, Japan, South Korea, and Australia have emerged as key contributors to the region's wallpaper market. Additionally, the increasing adoption of innovative wallpaper designs and patterns is fueling market growth further. APAC Wallpaper Market Size was valued at USD 0.55

All 5 Releases


More Releases for Tinea

Global Onychomycosis (Tinea Unguium) Drug Market
Onychomycosis (Tinea Unguium) Drug Market Forecast 2020-2026 The Global Onychomycosis (Tinea Unguium) Drug Market research report provides and in-depth analysis on industry- and economy-wide database for business management that could potentially offer development and profitability for players in this market. This is a latest report, covering the current COVID-19 impact on the market. The pandemic of Coronavirus (COVID-19) has affected every aspect of life globally. This has brought along several changes
Tinea Corporis Drugs Market Size, Share, Development by 2024
Global Info Research offers a latest published report on Tinea Corporis Drugs Market Analysis and Forecast 2019-2025 delivering key insights and providing a competitive advantage to clients through a detailed report. This report focuses on the key global Tinea Corporis Drugs players, to define, describe and analyze the value, market share, market competition landscape, SWOT analysis and development plans in next few years. To analyze the Tinea Corporis Drugs with respect
Tinea Pedis Treatment Market Dynamic Business Environment during 2017 - 2025
Global Tinea Pedis Treatment Market: Snapshot Athlete's foot known medically as tinea pedis, is a common skin infection of the feet caused by various kinds of fungi. Signs and symptoms often include itching, scaling, cracking and redness. In rare cases, the skin may blister. Athlete's foot fungus may infect any part of the foot, but most often grows between the toes. Apart from these areas, the fungus might develop at the
06-26-2018 | Health & Medicine
MRRSE
Tinea Pedis Treatment Market: Vesicular Tinea Pedis Disease Type Segment to Refl …
The global tinea pedis treatment market is projected to grow at a steady CAGR and surpass US$ 1.7 Bn in revenues by 2027. A new research study titled “Tinea Pedis Treatment Market: Vesicular Tinea Pedis Disease Type Segment to Reflect a High Growth Rate During the Forecast Period: Global Industry Analysis (2012 - 2016) and Opportunity Assessment (2017 - 2027)” added to the vast repository of Market Research Reports Search Engine
Tinea Pedis Treatment Market Key product innovations 2025
Global Tinea Pedis Treatment Market: Overview The global market for tinea pedis treatment has expanded on account of the rising awareness about skin infections and diseases amongst people. Tinea pedis, or Athlete’s foot, is a skin infection of the feet that is caused by fungus, and it results in excessive itching around the affected area. The discomfort caused by tinea pedis can become unbearable for the sufferers, and hence, it
Tinea Pedis Treatment Market Aforementioned survey till 2025
Global Tinea Pedis Treatment Market: Overview The global market for tinea pedis treatment has expanded on account of the rising awareness about skin infections and diseases amongst people. Tinea pedis, or Athlete’s foot, is a skin infection of the feet that is caused by fungus, and it results in excessive itching around the affected area. The discomfort caused by tinea pedis can become unbearable for the sufferers, and hence, it